| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/13/2011 | US8017342 Solid phase immobilization of phospholipids and cofactor proteins via covalent attachment |
| 09/13/2011 | US8017326 Methods of modulating cell death based on the Bit-1/AES regulatory pathway |
| 09/13/2011 | US8017325 Selection of high-producing cell lines |
| 09/13/2011 | US8017324 ENPP1 (PC-1) gene haplotype associated with the risk of obesity and type 2 diabetes and their applications |
| 09/13/2011 | US8017320 Method of detecting metastasizing cancer cells originating in stomach cancer |
| 09/13/2011 | US8017318 Method for detecting and/or quantifying a known function from a nucleic acid sample |
| 09/13/2011 | US8017317 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases |
| 09/13/2011 | US8017315 Mitochondrial localization of MUC1 |
| 09/13/2011 | US8017313 Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders |
| 09/13/2011 | US8017124 Use of the human protein Deleted in Malignant Brain Tumors 1 in the diagnosis, prophylaxis or treatment of diseases caused by an agent that has at least one accessible sulfate and/or phosphate group, such as a microorganism; ulcerative colitis; cancer of respiratory system or alimentary tract |
| 09/13/2011 | US8017103 Methods and compositions to diagnose trichomonas infection |
| 09/13/2011 | US8016991 Structural integrity; inexpensive; pH measurement; employs thick film technology and interdigital comb structure |
| 09/13/2011 | US8016990 Protective covers for gas sensor, gas sensor and gas sensor manufacturing method |
| 09/13/2011 | US8016774 Tissue penetration device |
| 09/13/2011 | US8015952 Engine fuel reformer monitoring |
| 09/13/2011 | CA2643355C Methods and compositions for opsonophagocytic assays |
| 09/13/2011 | CA2521773C Optical chemical sensing device with pyroelectric or piezoelectric transducer |
| 09/13/2011 | CA2504234C Process for amplifying nucleic acids |
| 09/13/2011 | CA2501641C Integrated sample cell and filter and system using same |
| 09/13/2011 | CA2480833C Sensitive immunochromatographic assay |
| 09/13/2011 | CA2480276C Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 09/13/2011 | CA2462855C System and apparatus for use in detecting microorganisms |
| 09/13/2011 | CA2433599C Test strip for simultaneous detection of a plurality of analytes |
| 09/13/2011 | CA2426580C Mass defect labeling for the determination of oligomer sequences |
| 09/13/2011 | CA2378187C Methods for treating therapy-resistant tumors |
| 09/13/2011 | CA2334878C Method and device for determining fibre orientation in a paper sample |
| 09/13/2011 | CA2329120C Mara family helix-turn-helix domains and their methods of use |
| 09/13/2011 | CA2329060C Aav5 vector and uses thereof |
| 09/13/2011 | CA2319575C Method for the determination of prosthetic infections |
| 09/13/2011 | CA2250792C Cocoa extract compounds and methods for making and using the same |
| 09/13/2011 | CA2236519C Methods of enhancing functioning of the large intestine |
| 09/13/2011 | CA2224127C Flagellin gene, flac of campylobacter |
| 09/09/2011 | WO2011109738A1 Biomarkers of osteoarthritis |
| 09/09/2011 | WO2011109678A1 Modulation of intracellular signaling |
| 09/09/2011 | WO2011109663A1 Neoplasia-specific autoantibodies and methods |
| 09/09/2011 | WO2011109637A1 Methods for classifying and treating breast cancers |
| 09/09/2011 | WO2011109584A2 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| 09/09/2011 | WO2011109572A2 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| 09/09/2011 | WO2011109525A1 Aging-Related Circulating Particle-Associated Lipoprotein B Oxidase (apoBNOX) and Inhibitors Thereof |
| 09/09/2011 | WO2011109503A1 Novel csf biomarkers for alzheimer's disease and frontotemporal lobar degeneration |
| 09/09/2011 | WO2011109459A2 Compositions, kits and methods for determining efficacy of a therapeutic agent and treating hair and skin diseases |
| 09/09/2011 | WO2011109451A1 Library compositions and methosds for acyclic identification of aptamers |
| 09/09/2011 | WO2011109448A1 Involvement of androgen/androgen receptor pathway in fabry disease |
| 09/09/2011 | WO2011109440A1 Biomarkers for theranostics |
| 09/09/2011 | WO2011109379A1 Methods and systems for extending dynamic range in assays for the detection of molecules or particles |
| 09/09/2011 | WO2011109372A1 Ultra-sensitive detection of molecules using dual detection methods |
| 09/09/2011 | WO2011109364A2 Ultra-sensitive detection of molecules or particles using beads or other capture objects |
| 09/09/2011 | WO2011109151A1 Ligand guanidinyl functionalized polymers |
| 09/09/2011 | WO2011109112A2 Method of detecting tau protein and tau fragments in serum |
| 09/09/2011 | WO2011109090A1 Affinity capture mass spectroscopy with a porous silicon biosensor |
| 09/09/2011 | WO2011109046A1 Sensing chemicals in aqueous environments |
| 09/09/2011 | WO2011108766A1 METHOD FOR DIAGNOSING A PROTEIN MISFOLDING DISEASE USING NERVE CELLS DERIVED FROM iPS CELLS |
| 09/09/2011 | WO2011108628A1 Gastric cancer marker, and method for detecting gastric cancer |
| 09/09/2011 | WO2011108626A1 Gastric cancer marker, and method for detecting gastric cancer |
| 09/09/2011 | WO2011108551A1 Diagnostic information distribution device and pathology diagnosis system |
| 09/09/2011 | WO2011108544A1 Uracil-specific fluorescence detection reaction and method for examining dihydropyrimidine dehydrogenase deficiency |
| 09/09/2011 | WO2011108540A1 Method and device for identifying nucleotide, and method and device for determining nucleotide sequence of polynucleotide |
| 09/09/2011 | WO2011108534A1 Method for diagnosis of amyotrophic lateral sclerosis (als) by analysis of prostaglandin d2 and metabolite thereof and creatinine, method for evaluation of effectiveness of medicinal agent in therapy, and system for estimation of tpgdm level in urine |
| 09/09/2011 | WO2011108454A1 Cell detection method and cell detection system |
| 09/09/2011 | WO2011107994A1 Methods of measuring protein stability |
| 09/09/2011 | WO2011107965A1 Kidney prognostic assay |
| 09/09/2011 | WO2011107962A1 Increase of myeloid microvesicles in the cerebrospinal fluid as biomarker of microglia/macrophage activation in neurological disorders |
| 09/09/2011 | WO2011107810A1 Conjugation reactions |
| 09/09/2011 | WO2011107664A1 Method for selecting patients for treatment with an egfr inhibitor |
| 09/09/2011 | WO2011107595A1 High throughput analysis of t-cell receptor repertoires |
| 09/09/2011 | WO2011107571A1 System and method for monitoring at least one blood parameter |
| 09/09/2011 | WO2011107568A1 System and method for administering medicaments on the basis of urine values |
| 09/09/2011 | WO2011107566A1 System for determining treatment-related data for the administration of drugs to patients to be treated taking into account important individual factors |
| 09/09/2011 | WO2011107489A1 Method for isolating target cells |
| 09/09/2011 | WO2011107482A2 Method of diagnostic of obesity |
| 09/09/2011 | WO2011107406A1 Analyte quantification using flow induced dispersion analysis |
| 09/09/2011 | WO2011107291A1 Antibodies against phosphorylcholine in combination therapy with biologic agents |
| 09/09/2011 | WO2011107274A1 Signal-emitting binding molecules, devices and method for the use thereof |
| 09/09/2011 | WO2011107238A1 Test strip for the detection of equol |
| 09/09/2011 | WO2011107076A1 Use of halogenated cyanocinnamic acid derivatives as matrices in maldi mass spectrometry |
| 09/09/2011 | WO2011107003A1 N-(4-aminobutyl)-n-ethylisoluminol functionalized gold nanoparticles, preparation method and application thereof |
| 09/09/2011 | WO2011106963A1 Luminescent nanogold functionalized by n-(4-aminobutyl)-n-ethylisoluminol, preparation and application thereof |
| 09/09/2011 | WO2011106898A1 Methods and systems for preparing irreversible inhibitors of protein tyrosine phosphatases |
| 09/09/2011 | WO2011106885A1 Oligomer-specific amyloid beta epitope and antibodies |
| 09/09/2011 | WO2011079937A3 Method for measuring analyte concentration in a liquid sample |
| 09/09/2011 | WO2011072874A3 Measurement array for a liquid, in particular for use in a milk collection array, and method for operating a milk collection array |
| 09/09/2011 | WO2011062381A3 Porous detecting sensor and a production method therefor |
| 09/09/2011 | WO2011053565A3 Compositions and methods for detecting a tauopathy |
| 09/09/2011 | WO2011050299A3 Adenovirus infection in animals |
| 09/09/2011 | WO2011050222A3 Therapeutic compositions that disrupt the hydrogen bonded ring structure in gp41 and methods for treating hiv |
| 09/09/2011 | WO2011050096A9 Methods and compositions for diagnosis and treatment of genetic and retinal disease |
| 09/09/2011 | WO2011049969A9 Synergistic interactions of phenolic compounds found in food |
| 09/09/2011 | WO2011037371A3 Portable blood analysis apparatus |
| 09/09/2011 | WO2010106347A3 Biomolecular labelling using multifunctional biotin analogues |
| 09/09/2011 | CA2800230A1 Method for selecting patients for treatment with an egfr inhibitor |
| 09/09/2011 | CA2795698A1 Modulation of intracellular signaling |
| 09/09/2011 | CA2791994A1 Involvement of androgen/androgen receptor pathway in fabry disease |
| 09/09/2011 | CA2791905A1 Biomarkers for theranostics |
| 09/09/2011 | CA2791893A1 Marker for detecting gastric cancer and method for detecting gastric cancer |
| 09/09/2011 | CA2791726A1 Conjugation reactions |
| 09/09/2011 | CA2791723A1 Ultra-low trypsin inhibitor soybean |
| 09/09/2011 | CA2791680A1 Compounds and therapeutic uses thereof |
| 09/09/2011 | CA2791676A1 Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients |
| 09/09/2011 | CA2791671A1 Marker for detecting gastric cancer and method for detecting gastric cancer |
| 09/09/2011 | CA2791655A1 Methods and systems for extending dynamic range in assays for the detection of molecules or particles |